
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination
Julia Brotherton, Sepehr N. Tabrizi, Samuel Phillips, et al.
International Journal of Cancer (2017) Vol. 141, Iss. 8, pp. 1576-1584
Open Access | Times Cited: 62
Julia Brotherton, Sepehr N. Tabrizi, Samuel Phillips, et al.
International Journal of Cancer (2017) Vol. 141, Iss. 8, pp. 1576-1584
Open Access | Times Cited: 62
Showing 1-25 of 62 citing articles:
The projected timeframe until cervical cancer elimination in Australia: a modelling study
Michaela Hall, Kate T. Simms, Jie‐Bin Lew, et al.
The Lancet Public Health (2018) Vol. 4, Iss. 1, pp. e19-e27
Open Access | Times Cited: 370
Michaela Hall, Kate T. Simms, Jie‐Bin Lew, et al.
The Lancet Public Health (2018) Vol. 4, Iss. 1, pp. e19-e27
Open Access | Times Cited: 370
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
Cyra Patel, Julia Brotherton, Alexis Pillsbury, et al.
Eurosurveillance (2018) Vol. 23, Iss. 41
Open Access | Times Cited: 252
Cyra Patel, Julia Brotherton, Alexis Pillsbury, et al.
Eurosurveillance (2018) Vol. 23, Iss. 41
Open Access | Times Cited: 252
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia
Michaela Hall, Kate T. Simms, Jie‐Bin Lew, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0185332-e0185332
Open Access | Times Cited: 62
Michaela Hall, Kate T. Simms, Jie‐Bin Lew, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0185332-e0185332
Open Access | Times Cited: 62
Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America
Rita Mariel Correa, Armando Baena, Joan Valls, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0272205-e0272205
Open Access | Times Cited: 31
Rita Mariel Correa, Armando Baena, Joan Valls, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0272205-e0272205
Open Access | Times Cited: 31
Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women
Karoliina Aro, Pekka Nieminen, Karolina Louvanto, et al.
Gynecologic Oncology (2019) Vol. 154, Iss. 2, pp. 354-359
Open Access | Times Cited: 52
Karoliina Aro, Pekka Nieminen, Karolina Louvanto, et al.
Gynecologic Oncology (2019) Vol. 154, Iss. 2, pp. 354-359
Open Access | Times Cited: 52
<p>Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus</p>
Zheng Quan Toh, Jennie Kosasih, Fiona M. Russell, et al.
Infection and Drug Resistance (2019) Vol. Volume 12, pp. 1951-1967
Open Access | Times Cited: 50
Zheng Quan Toh, Jennie Kosasih, Fiona M. Russell, et al.
Infection and Drug Resistance (2019) Vol. Volume 12, pp. 1951-1967
Open Access | Times Cited: 50
Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program
Suzanne M. Garland, Alyssa M. Cornall, Julia Brotherton, et al.
Vaccine (2018) Vol. 36, Iss. 23, pp. 3221-3230
Open Access | Times Cited: 48
Suzanne M. Garland, Alyssa M. Cornall, Julia Brotherton, et al.
Vaccine (2018) Vol. 36, Iss. 23, pp. 3221-3230
Open Access | Times Cited: 48
Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program
Dorothy A. Machalek, Jennifer M. Roberts, Suzanne M. Garland, et al.
The Medical Journal of Australia (2019) Vol. 211, Iss. 3, pp. 113-119
Open Access | Times Cited: 44
Dorothy A. Machalek, Jennifer M. Roberts, Suzanne M. Garland, et al.
The Medical Journal of Australia (2019) Vol. 211, Iss. 3, pp. 113-119
Open Access | Times Cited: 44
Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries
Suzanne M. Garland, Punnee Pitisuttithum, Hys Ngan, et al.
The Journal of Infectious Diseases (2018) Vol. 218, Iss. 1, pp. 95-108
Open Access | Times Cited: 43
Suzanne M. Garland, Punnee Pitisuttithum, Hys Ngan, et al.
The Journal of Infectious Diseases (2018) Vol. 218, Iss. 1, pp. 95-108
Open Access | Times Cited: 43
Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates
Jie‐Bin Lew, Eleonora Feletto, Stephen Wade, et al.
Public Health Research & Practice (2019) Vol. 29, Iss. 2
Open Access | Times Cited: 40
Jie‐Bin Lew, Eleonora Feletto, Stephen Wade, et al.
Public Health Research & Practice (2019) Vol. 29, Iss. 2
Open Access | Times Cited: 40
Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case–control study
Binhua Dong, Pengming Sun, Guanyu Ruan, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 4839-4851
Open Access | Times Cited: 34
Binhua Dong, Pengming Sun, Guanyu Ruan, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 4839-4851
Open Access | Times Cited: 34
A Lab-on-a-Chip Device Integrated DNA Extraction and Solid Phase PCR Array for the Genotyping of High-Risk HPV in Clinical Samples
Cancan Zhu, Anzhong Hu, Junsheng Cui, et al.
Micromachines (2019) Vol. 10, Iss. 8, pp. 537-537
Open Access | Times Cited: 33
Cancan Zhu, Anzhong Hu, Junsheng Cui, et al.
Micromachines (2019) Vol. 10, Iss. 8, pp. 537-537
Open Access | Times Cited: 33
Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China
Qingfeng Mai, Xiaohan Yang, Huan Cheng, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 4, pp. 965-971
Open Access | Times Cited: 31
Qingfeng Mai, Xiaohan Yang, Huan Cheng, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 4, pp. 965-971
Open Access | Times Cited: 31
Burden and Prevention of HPV. Knowledge, Practices and Attitude Assessment Among Pre-Adolescents and their Parents in Italy
Giancarlo Icardi, Claudio Costantino, Marcello Guido, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 3, pp. 326-342
Open Access | Times Cited: 30
Giancarlo Icardi, Claudio Costantino, Marcello Guido, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 3, pp. 326-342
Open Access | Times Cited: 30
Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled Analysis
Megan A. Smith, Michaela Hall, Marion Saville, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 30, Iss. 2, pp. 268-277
Open Access | Times Cited: 29
Megan A. Smith, Michaela Hall, Marion Saville, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 30, Iss. 2, pp. 268-277
Open Access | Times Cited: 29
Perceived facilitators and barriers to the uptake of the human papillomavirus (HPV) vaccine among adolescents of Arabic-speaking mothers in NSW, Australia: A qualitative study
Faeza Netfa, Catherine King, Cristyn Davies, et al.
Vaccine X (2023) Vol. 14, pp. 100335-100335
Open Access | Times Cited: 11
Faeza Netfa, Catherine King, Cristyn Davies, et al.
Vaccine X (2023) Vol. 14, pp. 100335-100335
Open Access | Times Cited: 11
The Prevalence of Human Papillomavirus Genotypes in Women with Precancerous Lesions and Cervical Cancer in Arequipa, Peru
Gonzalo Arturo Medina Bueno, Deyné Maribel Ticona Ramos, Claudia Maritza Bárcenas Cuadros, et al.
Life (2025) Vol. 15, Iss. 2, pp. 267-267
Open Access
Gonzalo Arturo Medina Bueno, Deyné Maribel Ticona Ramos, Claudia Maritza Bárcenas Cuadros, et al.
Life (2025) Vol. 15, Iss. 2, pp. 267-267
Open Access
The Epithelial Immune Response to Human Papillomavirus Infection
Shyantani Roy-Biswas, Merilyn Hibma
Pathogens (2025) Vol. 14, Iss. 5, pp. 464-464
Open Access
Shyantani Roy-Biswas, Merilyn Hibma
Pathogens (2025) Vol. 14, Iss. 5, pp. 464-464
Open Access
HPV42
Karen L. Talia, David Hawkes, Gloria Zhang, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Karen L. Talia, David Hawkes, Gloria Zhang, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study
Li Dong, Margaret Wang, Xue-lian Zhao, et al.
Gynecologic Oncology (2017) Vol. 148, Iss. 1, pp. 103-110
Open Access | Times Cited: 30
Li Dong, Margaret Wang, Xue-lian Zhao, et al.
Gynecologic Oncology (2017) Vol. 148, Iss. 1, pp. 103-110
Open Access | Times Cited: 30
The Relationships Between Social Media and Human Papillomavirus Awareness and Knowledge: Cross-sectional Study
Soojung Jo, Keenan A. Pituch, Nancy Howe
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 9, pp. e37274-e37274
Open Access | Times Cited: 15
Soojung Jo, Keenan A. Pituch, Nancy Howe
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 9, pp. e37274-e37274
Open Access | Times Cited: 15
DNA Biosensor Based on Double-Layer Discharge for the Detection of HPV Type 16
José Espinosa, Marisol Galván, Arturo S. Quiñones, et al.
Sensors (2019) Vol. 19, Iss. 18, pp. 3956-3956
Open Access | Times Cited: 23
José Espinosa, Marisol Galván, Arturo S. Quiñones, et al.
Sensors (2019) Vol. 19, Iss. 18, pp. 3956-3956
Open Access | Times Cited: 23
Types and viral load of human papillomavirus, and vaginal microbiota in vaginal intraepithelial neoplasia: a cross-sectional study
Fangyue Zhou, Qi Zhou, Zhongyi Zhu, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 21, pp. 1408-1408
Open Access | Times Cited: 23
Fangyue Zhou, Qi Zhou, Zhongyi Zhu, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 21, pp. 1408-1408
Open Access | Times Cited: 23
Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix
Frederik A. Stuebs, Paul Gaß, Anna K. Dietl, et al.
Archives of Gynecology and Obstetrics (2021) Vol. 304, Iss. 3, pp. 751-758
Closed Access | Times Cited: 20
Frederik A. Stuebs, Paul Gaß, Anna K. Dietl, et al.
Archives of Gynecology and Obstetrics (2021) Vol. 304, Iss. 3, pp. 751-758
Closed Access | Times Cited: 20
Human papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule
Julia Brotherton
Australian Journal of General Practice (2018) Vol. 47, Iss. 7, pp. 417-421
Open Access | Times Cited: 21
Julia Brotherton
Australian Journal of General Practice (2018) Vol. 47, Iss. 7, pp. 417-421
Open Access | Times Cited: 21